Comparison of subxiphoid vs. intercostal video-assisted thoracoscopic surgery for thymectomy
Year: 2026
Type: article
Study designs: Systematic Review, Meta-Analysis
Abstract: Complete surgical resection, primarily through thymectomy, is an effective treatment for thymoma in anterior mediastinal tumors (AMTs). Inconsistent evidence exists regarding the relative efficacy of subxiphoid video-assisted thoracoscopic surgery (SVATS) compared to intercostal video-assisted thoracoscopic surgery (IVATS) for thymoma in anterior mediastinal tumors (AMTs) This study aimed to compare the benefits of SVATS vs. IVATS for thymectomy. A literature search identified comparative studies reporting perioperative outcomes of SVATS vs. IVATS for thymectomy. SVATS and IVATS were the experimental and control groups, respectively. Odds ratios (OR) and MD mean differences (MDs) with 95% confidence intervals (95% CIs) were calculated using fixed-or random-effects models. Sixteen studies met the selection criteria, and included 1785 participants. Of these, 791 patients underwent SVATS, whereas 994 underwent IVATS. SVATS demonstrated better perioperative outcomes than IVATS regarding hospital stay (days) (MD = -0.65, 95% CI -1.12 to -0.18) and chest tube duration (days) (MD = -0.45, 95% CI -0.75 to -0.16). Sub-group meta-analysis indicated no significant reduction in operative time (min) with SVATS compared to IVATS for Asian patients (MD = 2.03, 95% CI -9.49 to 13.56). Operative time (min) (MD = 7.85, 95% CI -4.24 to 19.94, P = 0.20), complication rates (OR = 1.02, 95% CI 0.74–1.40; P = 0.91), and estimated blood loss (mL) (MD = -5.63, 95% CI -11.97 to 0.72, P = 0.08) were comparable between SVATS and IVATS. Our study suggested that the SVATS is a safe and feasible alternative to IVATS and may offer perioperative advantages in selected patients when performed by qualified surgeons. Further studies are required to confirm these findings.
Source: BMC Cancer
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,390
OpenAlex ID: W7226024152
